Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Endometrial Neoplasms × spartalizumab × Clear all

Phase

Status

Sponsor Class

INDUSTRY 4 OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Hepatocellular 16 Neoplasm Metastasis 11 Nasopharyngeal Carcinoma 9 Melanoma 9 Carcinoma, Non-Small-Cell Lung 9 Pancreatic Neoplasms 7 Locally Advanced Rectal Cancer 7 Colorectal Neoplasms 7 Rectal Neoplasms 6 Stomach Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 4 Neoplasms 4 Carcinoma, Renal Cell 4 Recurrence 3 Lymphoma, Extranodal NK-T-Cell 3 Glioblastoma 3 Esophageal Neoplasms 3 Uterine Cervical Neoplasms 2 Solid Tumor 2 Prostatic Neoplasms 2 Nasopharyngeal Neoplasms 2 Lymphoma 2 Lung Neoplasms 2 Kidney Neoplasms 2 Gastrointestinal Stromal Tumors 2 Epstein-Barr Virus Infections 2 Cholangiocarcinoma 2 Breast Neoplasms 2 Advanced Solid Tumor 2 Urinary Bladder Neoplasms 1

Interventions

Paclitaxel 35 Carboplatin 28 pembrolizumab 22 Surveys and Questionnaires 20 Letrozole 14 Radiotherapy 13 Bevacizumab 13 Blood Specimen Collection 12 Metformin 11 Megestrol Acetate 11 olaparib 10 dostarlimab 10 Observation 9 Medroxyprogesterone Acetate 9 Indocyanine Green 9 Cisplatin 9 durvalumab 8 lenvatinib 7 Sentinel Lymph Node Biopsy 7 Radiation 7 Magnetic Resonance Spectroscopy 7 Lymph Node Excision 7 Early Intervention, Educational 7 atezolizumab 6 abemaciclib 6 Taxes 6 Specimen Handling 6 Methods 6 Hysterectomy 6 Everolimus 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07319429 2026-03-13

FEMUS

Fudan University

Phase 2/3 Recruiting

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡